| Darr W Leutz, MD | |
|
4800 Maine St, Quincy, IL 62305-5875 | |
| (217) 214-0444 | |
| Not Available |
| Full Name | Darr W Leutz |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 36 Years |
| Location | 4800 Maine St, Quincy, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225069057 | NPI | - | NPPES |
| 036088511 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 036088511 (Illinois) | Primary |
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 036088511 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blessing Hospital | Quincy, IL | Hospital |
| Illini Community Hospital | Pittsfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blessing Hospital | 3072422534 | 345 |
News Archive
Research out of the George Washington University (GW), published in the journal Proceedings of the National Academy of Sciences (PNAS), reveals another piece of the puzzle in a genetic developmental disorder that causes behavioral diseases such as autism.
Virtual reality is being used to train and prepare the next generation of paramedics to respond to terrorist attacks and natural disasters.
Eli Lilly and Company's investigational medicine ixekizumab was statistically superior to etanercept and placebo on all skin clearance measures in Phase 3 studies, the company said today in disclosing top-line results from its pivotal UNCOVER studies in moderate-to-severe plaque psoriasis.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
If patients with suspected coronary artery disease are excluded from further screening because of a low Framingham score, many patients with substantial atherosclerosis (a build-up of plaque inside the arteries) will be missed, according to a study published in the May issue of the American Journal of Roentgenology.
› Verified 6 days ago
| Entity Name | Blessing Corporate Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851311641 PECOS PAC ID: 5991616138 Enrollment ID: O20050222000479 |
News Archive
Research out of the George Washington University (GW), published in the journal Proceedings of the National Academy of Sciences (PNAS), reveals another piece of the puzzle in a genetic developmental disorder that causes behavioral diseases such as autism.
Virtual reality is being used to train and prepare the next generation of paramedics to respond to terrorist attacks and natural disasters.
Eli Lilly and Company's investigational medicine ixekizumab was statistically superior to etanercept and placebo on all skin clearance measures in Phase 3 studies, the company said today in disclosing top-line results from its pivotal UNCOVER studies in moderate-to-severe plaque psoriasis.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
If patients with suspected coronary artery disease are excluded from further screening because of a low Framingham score, many patients with substantial atherosclerosis (a build-up of plaque inside the arteries) will be missed, according to a study published in the May issue of the American Journal of Roentgenology.
› Verified 6 days ago
| Entity Name | Blessing Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1114471737 PECOS PAC ID: 3072422534 Enrollment ID: O20161005001836 |
News Archive
Research out of the George Washington University (GW), published in the journal Proceedings of the National Academy of Sciences (PNAS), reveals another piece of the puzzle in a genetic developmental disorder that causes behavioral diseases such as autism.
Virtual reality is being used to train and prepare the next generation of paramedics to respond to terrorist attacks and natural disasters.
Eli Lilly and Company's investigational medicine ixekizumab was statistically superior to etanercept and placebo on all skin clearance measures in Phase 3 studies, the company said today in disclosing top-line results from its pivotal UNCOVER studies in moderate-to-severe plaque psoriasis.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
If patients with suspected coronary artery disease are excluded from further screening because of a low Framingham score, many patients with substantial atherosclerosis (a build-up of plaque inside the arteries) will be missed, according to a study published in the May issue of the American Journal of Roentgenology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darr W Leutz, MD 1005 Broadway St, Quincy, IL 62301-2834 Ph: (217) 223-8400 | Darr W Leutz, MD 4800 Maine St, Quincy, IL 62305-5875 Ph: (217) 214-0444 |
News Archive
Research out of the George Washington University (GW), published in the journal Proceedings of the National Academy of Sciences (PNAS), reveals another piece of the puzzle in a genetic developmental disorder that causes behavioral diseases such as autism.
Virtual reality is being used to train and prepare the next generation of paramedics to respond to terrorist attacks and natural disasters.
Eli Lilly and Company's investigational medicine ixekizumab was statistically superior to etanercept and placebo on all skin clearance measures in Phase 3 studies, the company said today in disclosing top-line results from its pivotal UNCOVER studies in moderate-to-severe plaque psoriasis.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
If patients with suspected coronary artery disease are excluded from further screening because of a low Framingham score, many patients with substantial atherosclerosis (a build-up of plaque inside the arteries) will be missed, according to a study published in the May issue of the American Journal of Roentgenology.
› Verified 6 days ago
William J. Holt, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1025 Maine St, Quincy, IL 62301 Phone: 217-222-6550 | |
David G. Levinsohn, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4800 Maine St, Quincy, IL 62305 Phone: 217-214-0444 | |
Kevin M Hilton, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1025 Maine St, Quincy, IL 62301 Phone: 217-222-6550 | |
Bryan James Pimlott, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4800 Maine St, Quincy, IL 62305 Phone: 217-214-0444 | |
Dr. Josue David Acevedo, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4800 Maine St, Quincy, IL 62305 Phone: 217-214-0444 | |
George E. Crickard Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1025 Maine St, Quincy, IL 62301 Phone: 217-222-6550 |